Solbinsiran
Solbinsiran (LY3561774) is a GalNAc-conjugated siRNA targeting ANGPTL3. Solbinsiran mediates RNA interference against hepatic ANGPTL3 mRNA, reducing ANGPTL3 translation. Solbinsiran lowers hepatocyte ANGPTL3 mRNA and serum ANGPTL3 protein levels. Solbinsiran can be used in research on mixed dyslipidemia.
For research use only. We do not sell to patients.
- CAS No.: 2718150-11-7
- Formula: C653H859O412N229F11P57S6
- Molecular Weight:20674.90
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
|
ANGPTL3 |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Solbinsiran (3 mg/kg; s.c.; single dose) produces durable hepatic ANGPTL3 mRNA knockdown and reduces circulating ANGPTL3 protein levels in cynomolgus monkeys[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:CD1 (female; 6-8 weeks of age)[1]
-
Dosage:1 mg/kg
-
Administration:s.c.; single dose
-
Result:A single 1 mg/kg subcutaneous dose reduced human ANGPTL3 mRNA levels by 65% compared with vehicle-treated mice.
-
Animal Model:Cynomolgus monkeys[1]
-
Dosage:3 mg/kg
-
Administration:s.c.; single dose
-
Result:A single 3 mg/kg subcutaneous dose produced mean reductions in hepatic ANGPTL3 mRNA expression of up to 72.9% and in serum ANGPTL3 protein of up to 68.6% at day 28 compared with vehicle-treated monkeys.
Hepatic mRNA knockdown remained >50% 12 weeks after the single dose.
Chemical Information
-
CAS No. 2718150-11-7
-
Molecular Weight 20674.90
-
Formula C653H859O412N229F11P57S6
-
SMILES
[Solbinsiran]
-
Synonyms
LY3561774
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)